As reported in Figure 1, the main therapeutic groups used by patients in polypharmacy were mineral supplements, agents acting on the renin–angiotensin system, and drugs used for the treatment of bone disease, while the most frequent comorbidity was uncomplicated hypertension, followed by valvular disease, uncomplicated diabetes, and depression. The gene discussed is REN; the disease is diabetes mellitus.